$339 Million is the total value of Hudson Executive Capital LP's 7 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CATM | Buy | CARDTRONICS PLC | $142,512,000 | +295.5% | 6,387,830 | +228.3% | 42.04% | +143.0% |
EGRX | EAGLE PHARMACEUTICALS INC | $51,162,000 | -1.4% | 971,000 | 0.0% | 15.09% | -39.4% | |
ATRC | Buy | ATRICURE INC | $48,717,000 | +33.2% | 2,374,119 | +18.4% | 14.37% | -18.2% |
CIT | CIT GROUP INC | $43,855,000 | +4.6% | 851,557 | 0.0% | 12.94% | -35.7% | |
ACOR | ACORDA THERAPEUTICS INC | $31,140,000 | +10.3% | 1,316,700 | 0.0% | 9.19% | -32.3% | |
CVRS | CORINDUS VASCULAR ROBOTICS I | $15,531,000 | +35.6% | 11,336,154 | 0.0% | 4.58% | -16.7% | |
FCB | Buy | FCB FINL HLDGS INCcl a | $6,081,000 | +178.4% | 119,000 | +176.7% | 1.79% | +71.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
DEUTSCHE BANK AG | 21 | Q3 2023 | 88.0% |
EAGLE PHARMACEUTICALS INC | 16 | Q4 2019 | 34.5% |
NATERA INC | 15 | Q4 2022 | 4.6% |
CARDTRONICS PLC | 14 | Q1 2021 | 43.3% |
VIEWRAY INC | 14 | Q2 2023 | 8.2% |
ATRICURE INC | 13 | Q3 2019 | 20.9% |
CIT GROUP INC | 11 | Q2 2018 | 26.4% |
TIVITY HEALTH INC | 11 | Q1 2022 | 12.3% |
CORINDUS VASCULAR ROBOTICS I | 11 | Q3 2019 | 9.7% |
CANTALOUPE INC | 10 | Q3 2023 | 11.8% |
View Hudson Executive Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
ViewRay, Inc. | July 21, 2023 | 6,752,093 | 3.7% |
Akoya Biosciences, Inc. | February 07, 2023 | 1,892,204 | 5.0% |
Liberated Syndication Inc. | March 23, 2022 | 2,400,000 | 8.6% |
eHealth, Inc. | March 11, 2022 | 750,501 | 2.8% |
Talkspace, Inc. | November 17, 2021 | 17,980,600 | 11.2% |
USA TECHNOLOGIES INC | February 26, 2021 | 11,995,765 | 16.9% |
Cardtronics plc | December 15, 2020 | 8,644,880 | 19.4% |
TIVITY HEALTH, INC. | May 11, 2020 | 4,795,310 | 9.9% |
EAGLE PHARMACEUTICALS, INC. | January 16, 2020 | 361,897 | 2.6% |
Corindus Vascular Robotics, Inc.Sold out | October 31, 2019 | 0 | 0.0% |
View Hudson Executive Capital LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
144 | 2024-02-21 |
4 | 2024-02-21 |
SC 13D/A | 2024-02-21 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
SC 13D/A | 2023-07-21 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
SC 13D/A | 2023-02-07 |
View Hudson Executive Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.